Literature DB >> 8040303

Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene.

M Adams1, C Matthews, T N Collingwood, Y Tone, P Beck-Peccoz, K K Chatterjee.   

Abstract

Resistance to thyroid hormone (RTH), with elevated serum free thyroid hormones and nonsuppressed thyrotropin levels, is either relatively asymptomatic, suggesting a generalized disorder (GRTH) or associated with thyrotoxic features, indicating possible selective pituitary resistance (PRTH). 20 GRTH and 9 PRTH cases, sporadic or dominantly inherited, were analyzed. Affected individuals were heterozygous for single nucleotide substitutions in the thyroid hormone receptor beta gene, except for a single case of a seven nucleotide insertion. With one exception, the corresponding 13 novel and 7 known codon changes localized to and extended the boundaries of two mutation clusters in the hormone-binding domain of the receptor. 15 kindreds shared 6 different mutations, and haplotype analyses of the mutant allele showed that they occurred independently. The majority (14 out of 19) of the recurrent but a minority (1 out of 10) of unique mutations were transitions of CpG dinucleotides. Mutant receptor binding to ligand was moderately or severely impaired and did not correlate with the magnitude of thyroid dysfunction. There was no association between clinical features and the nature or location of a receptor mutation. These observations suggest that GRTH and PRTH are phenotypic variants of the same genetic disorder, whose clinical expression may be modulated by other non-mutation-related factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040303      PMCID: PMC296123          DOI: 10.1172/JCI117362

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.

Authors:  R Parrilla; A J Mixson; J A McPherson; J H McClaskey; B D Weintraub
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene.

Authors:  S J Usala; A E Bale; N Gesundheit; C Weinberger; R W Lash; F E Wondisford; O W McBride; B D Weintraub
Journal:  Mol Endocrinol       Date:  1988-12

Review 3.  The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions.

Authors:  D N Cooper; M Krawczak
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

4.  A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors.

Authors:  B M Forman; C R Yang; M Au; J Casanova; J Ghysdael; H H Samuels
Journal:  Mol Endocrinol       Date:  1989-10

5.  The CpG dinucleotide and human genetic disease.

Authors:  D N Cooper; H Youssoufian
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

6.  A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.

Authors:  S J Usala; G E Tennyson; A E Bale; R W Lash; N Gesundheit; F E Wondisford; D Accili; P Hauser; B D Weintraub
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

7.  Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".

Authors:  M C Gershengorn; B D Weintraub
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

8.  Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets.

Authors:  M R Hughes; P J Malloy; D G Kieback; R A Kesterson; J W Pike; D Feldman; B W O'Malley
Journal:  Science       Date:  1988-12-23       Impact factor: 47.728

9.  Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta.

Authors:  A Sakurai; K Takeda; K Ain; P Ceccarelli; A Nakai; S Seino; G I Bell; S Refetoff; L J DeGroot
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995).

Authors:  G Williams; M Kraenzlin; L Sandler; J Burrin; A Law; S Bloom; G F Joplin
Journal:  Acta Endocrinol (Copenh)       Date:  1986-09
View more
  46 in total

Review 1.  Resistance to thyroid hormone.

Authors:  R E Weiss; S Refetoff
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Genetic analyses and evaluation of peripheral parameters of thyroid hormone action for the differential diagnosis of RTH. A novel heterozygous missense mutation (M334T) discovered.

Authors:  D Mannavola; G Vannucchi; L Fugazzola; N Cerutti; L Persani; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

3.  Autoimmunity in patients with resistance to thyroid hormone.

Authors:  Marla S Barkoff; Masha Kocherginsky; João Anselmo; Roy E Weiss; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

4.  Resistance to thyroid hormone associated with autoimmune thyroid disease in a Turkish family.

Authors:  D Y Aksoy; A Gurlek; U Ringkananont; R E Weiss; S Refetoff
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

5.  Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity.

Authors:  Meghan D Rosen; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2009-04-30

6.  A dominant-negative thyroid hormone receptor blocks amphibian metamorphosis by retaining corepressors at target genes.

Authors:  Daniel R Buchholz; Shao-Chung Victor Hsia; Liezhen Fu; Yun-Bo Shi
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Thyroid hormone receptor beta gene mutation (P453A) in a family producing resistance to thyroid hormone.

Authors:  T Bayraktaroglu; J Noel; F Alagol; N Colak; N M Mukaddes; S Refetoff
Journal:  Exp Clin Endocrinol Diabetes       Date:  2008-06-17       Impact factor: 2.949

8.  Detection of a new de novo mutation at codon 251 of exon 8 of thyroid hormone receptor beta gene in an Italian kindred with resistance to thyroid hormone.

Authors:  E Macchia; M Agostini; G Sarkissian; G Giorgilli; D Canale; G Scartabelli; A Margotat; J Torresani; A Pinchera
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

9.  A conserved lysine in the thyroid hormone receptor-alpha1 DNA-binding domain, mutated in hepatocellular carcinoma, serves as a sensor for transcriptional regulation.

Authors:  Ivan H Chan; Martin L Privalsky
Journal:  Mol Cancer Res       Date:  2010-01-06       Impact factor: 5.852

Review 10.  Germline and somatic thyroid hormone receptor mutations in man.

Authors:  P M Yen; S Y Cheng
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.